Aspirin reduces the incidence of metastasis in a preclinical study of Braf mutant colorectal cancer

被引：0
|
作者：
Kane, Alexandra [1 ]
Liu, Cheng [1 ]
Fennell, Lochlan [1 ]
McKeone, Diane [1 ]
Borowsky, Jennifer [1 ]
Leggett, Barbara [1 ]
Whitehall, Vicki [1 ]
机构：
[1] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-1103
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1103
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Targeted therapy for BRAF-mutant colorectal cancer
    Gunjur, Ashray
    LANCET ONCOLOGY, 2019, 20 (11): : E618 - E618
  • [22] Resistance to RAF Inhibition in BRAF Mutant Colorectal Cancer
    Corcoran, Ryan B.
    ONCOLOGIST, 2012, 17 : 2 - 2
  • [23] Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and Metastasis
    Young, Arabella
    Ngiow, Shin Foong
    Madore, Jason
    Reinhardt, Julia
    Landsberg, Jennifer
    Chitsazan, Arash
    Rautela, Jai
    Bald, Tobias
    Barkauskas, Deborah S.
    Ahern, Elizabeth
    Huntington, Nicholas D.
    Schadendorf, Dirk
    Long, Georgina V.
    Boyle, Glen M.
    Hoelzel, Michael
    Scolyer, Richard A.
    Smyth, Mark J.
    CANCER RESEARCH, 2017, 77 (17) : 4684 - 4696
  • [24] Aspirin use and colorectal cancer incidence in the physicians' health study (PHS).
    Sturmer, T
    Glynn, RJ
    Lee, IM
    Manson, JE
    Hennekens, CH
    Buring, JE
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1996, 143 (11) : 248 - 248
  • [25] BRAF-mutant colorectal cancer, a different breed evolving
    Lai, Eleonora
    Pretta, Andrea
    Impera, Valentino
    Mariani, Stefano
    Giampieri, Riccardo
    Casula, Laura
    Pusceddu, Valeria
    Coni, Pierpaolo
    Fanni, Daniela
    Puzzoni, Marco
    Demurtas, Laura
    Ziranu, Pina
    Faa, Gavino
    Scartozzi, Mario
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2018, 18 (06) : 499 - 512
  • [26] Molecular targeted therapy of BRAF-mutant colorectal cancer
    Ducreux, Michel
    Chamseddine, Ali
    Laurent-Puig, Pierre
    Smolenschi, Cristina
    Hollebecque, Antoine
    Dartigues, Peggy
    Samallin, Emmanuelle
    Boige, Valerie
    Malka, David
    Gelli, Maximiliano
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [27] BRAF mutant colorectal cancer: prognosis, treatment, and new perspectives
    Sanz-Garcia, E.
    Argiles, G.
    Elez, E.
    Tabernero, J.
    ANNALS OF ONCOLOGY, 2017, 28 (11) : 2648 - 2657
  • [28] Kinase Inhibitor in a Patient with BRAF-mutant Colorectal Cancer
    Sakumura, Miho
    Ando, Takayuki
    Ueda-Consolvo, Tomoko
    Motoo, Iori
    Mihara, Hiroshi
    Kajiura, Shinya
    Teramoto, Akira
    Nanjo, Sohachi
    Fujinami, Haruka
    Yasuda, Ichiro
    INTERNAL MEDICINE, 2022, 61 (11) : 1707 - 1712
  • [29] Treatment options in BRAF-mutant metastatic colorectal cancer
    Bernabe-Ramirez, Carolina
    Patel, Rajvi
    Chahal, Jaspreet
    Saif, Muhammad Wasif
    ANTI-CANCER DRUGS, 2020, 31 (06) : 545 - 557
  • [30] Targeting the dopamine receptor 2 in BRAF mutant colorectal cancer
    Javadi, Arman
    Forsythe, Nicholas
    Refaat, Alaa
    Weir, Jessica-Ann
    Khawaja, Hajrah
    Waugh, David
    Tarapore, Rohinton
    Allen, Joshua E.
    Johnston, Patrick
    Van Schaeybroeck, Sandra
    CANCER RESEARCH, 2018, 78 (13)
12345